Everence Capital Management Inc Ionis Pharmaceuticals Inc Transaction History
Everence Capital Management Inc
- $1.54 Billion
- Q4 2024
A detailed history of Everence Capital Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Everence Capital Management Inc holds 6,770 shares of IONS stock, worth $212,781. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,770Holding current value
$212,781% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$473 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$445 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$324 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$275 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$247 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.46B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...